Studi In Silico Molekuler Turunan Kumarin sebagai Kandidat Inhibitor ER-α pada Antikanker Payudara
Cancer is one of the leading causes of death worldwide, prompting the development of new candidate therapeutic agents. Coumarin derivatives have potential anticancer activity, but their pharmacokinetic characteristics, toxicity, and binding affinity for the target receptor require evaluation. This study aims to evaluat...